Migraine and gastroparesis from a gastroenterologist's perspective

Headache

Volumn 53, Issue SUPPL.1, 2013, Pages 4-10

  Parkman, Henry P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 hydroxytryptamine1B 1D agonist; gastroparesis; headache; migraine; triptan

Indexed keywords

ACETYLSALICYLIC ACID; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIMIGRAINE AGENT; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; BOTULINUM TOXIN A; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; METOCLOPRAMIDE; PHENOTHIAZINE DERIVATIVE; PROKINETIC AGENT; SALICYLIC ACID; SEROTONIN 3 ANTAGONIST; TOLFENAMIC ACID; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; AREA UNDER THE CURVE; ARTICLE; AUTONOMIC NEUROPATHY; BARIATRIC SURGERY; BLOATING; BREATH ANALYSIS; CARDINAL SYMPTOM INDEX; CLINICAL ASSESSMENT TOOL; CONTROLLED CLINICAL TRIAL (TOPIC); DIET THERAPY; DIETARY FIBER; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; ELECTROSTIMULATION THERAPY; EPIGASTRIC FULLNESS; EPIGASTRIC PAIN; EPISODIC MIGRAINE; HOSPITALIZATION; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE CELL; JEJUNOSTOMY TUBE; LOW FAT DIET; MIGRAINE; NAUSEA; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS SURGERY; PATHOGENESIS; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; SATIETY; SEX DIFFERENCE; SMOOTH MUSCLE FIBER; STOMACH EMPTYING; STOMACH PARESIS; STOMACH PH; STOMACH PRESSURE; STOMACH SCINTISCANNING; SYMPTOM ASSESSMENT; TIME TO MAXIMUM PLASMA CONCENTRATION; UNITED STATES; VAGUS NERVE INJURY;

ADMINISTRATION, ORAL; GASTROINTESTINAL TRACT; GASTROPARESIS; HUMANS; MIGRAINE DISORDERS;

EID: 84878500448     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12112     Document Type: Article

References (30)

1. Tang DM, Friedenberg FK,. Gastroparesis: Approach, diagnostic evaluation, and management. Dis Mon. 2011; 57: 74-101.
2. Jung HK, Choung RS, Locke GR III, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009; 136: 1225-1233.
3. Wang YR, Fisher RS, Parkman HP,. Gastroparesis-related hospitalizations in the United States: Trends, characteristics, and outcomes, 1995-2004. Am J Gastroenterol. 2008; 103: 313-322.
4. Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW,. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998; 43: 2398-2404.
5. Cherian D, Sachdeva P, Fisher RS, Parkman HP,. Abdominal pain is a frequent symptom of gastroparesis. Clin Gastroenterol Hepatol. 2010; 8: 676-681.
6. Hasler WL, Wilson LA, Parkman HP, et al. Bloating in gastroparesis: Severity, impact, and associated factors. Am J Gastroenterol. 2011; 106: 1492-1502.
7. Revicki DA, Rentz AM, Dubois D, et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: The Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther. 2003; 18: 141-150.
8. Revicki DA, Camilleri M, Kuo B, et al. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther. 2009; 30: 670-680.
9. Hasler WL,. Gastroparesis: Pathogenesis, diagnosis, and management. Nat Rev Gastroenterol Hepatol. 2011; 8: 438-453.
10. Hasler WL,. Gastroparesis-current concepts and considerations. Medscape J Med. 2008; 10: 16-22.
11. Wo JM, Parkman HP,. Motility and functional disorders of the stomach: Diagnosis and management of functional dyspepsia and gatroparesis. Pract Gastroenterol. 2006; 26: 23-48.
12. Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011; 140: 101-115.
13. Parkman HP,. Assessment of gastric emptying and small-bowel motility: Scintigraphy, breath tests, manometry, and SmartPill. Gastrointest Endosc Clin N Am. 2009; 19: 49-55.
14. Horowitz M, Maddox AF, Wishart JM, Harding PE, Chatterton BE, Shearman DJ,. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med. 1991; 18: 229-234.
15. Pasricha PJ, Colvin R, Yates K, et al. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol. 2011; 9: 567-576.e1-4.
16. McCallum RW, George SJ,. Gastric dysmotility and gastroparesis. Curr Treat Options Gastroenterol. 2001; 4: 179-191.
17. Moore JG, Christian PE, Brown JA, et al. Influence of meal weight and caloric content on gastric emptying of meals in man. Dig Dis Sci. 1984; 29: 513-519.
18. Moore JG, Christian PE, Coleman RE,. Gastric emptying of varying meal weight and composition in man. Evaluation by dual liquid- and solid-phase isotopic method. Dig Dis Sci. 1981; 26: 16-22.
19. Stapleton J, Wo JM,. Current treatment of nausea and vomiting associated with gastroparesis: Antiemetics, prokinetics, tricyclics. Gastrointest Endosc Clin N Am. 2009; 19: 57-72.
20. Aurora SK, Kori SH, Barrodale P, McDonald SA, Haseley D,. Gastric stasis in migraine: More than just a paroxysmal abnormality during a migraine attack. Headache. 2006; 46: 57-63.
21. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd ed. Cephalalgia. 2004; 24 (Suppl. 1): 9-160.
22. Volans GN,. Migraine and drug absorption. Clin Pharmacokinet. 1978; 3: 313-318.
23. Tokola RA, Neuvonen PJ,. Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid. Br J Clin Pharmacol. 1984; 17: 667-675.
24. Tokola RA, Neuvonen PJ,. Effect of migraine attacks on paracetamol absorption. Br J Clin Pharmacol. 1984; 18: 867-871.
25. Tokola RA,. The effect of metoclopramide and prochlorperazine on the absorption of effervescent paracetamol in migraine. Cephalalgia. 1988; 8: 139-147.
26. Thomsen LL, Dixon R, Lassen LH, et al. 311C90 (zolmitriptan), a novel centrally and peripherally acting oral 5-hydroxytryptamine-1D agonist: A comparison of its absorption during a migraine attack and in a migraine-free period. Cephalalgia. 1996; 16: 270-275.
27. Haberer LJ, Walls CM, Lener SE, Taylor DR, McDonald SA,. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine. Headache. 2010; 50: 357-373.
28. Scott AK,. Sumatriptan clinical pharmacokinetics. Clin Pharmacokinet. 1994; 27: 337-344.
29. Aurora S, Kori S, Barrodale P, Nelsen A, McDonald S,. Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache. 2007; 47: 1443-1446.
30. Boyle R, Behan PO, Sutton JA,. A correlation between severity of migraine and delayed gastric emptying measured by an epigastric impedance method. Br J Clin Pharmacol. 1990; 30: 405-409.